Back to search

Article

Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides

2022-09-13

Abstract excerpt

<h4>ABSTRACT</h4> Dampening functional levels of the mitochondrial deubiquitylating enzyme USP30 has been suggested as an effective therapeutic strategy against neurodegenerative disorders such as Parkinson’s Disease. USP30 inhibition may counteract the deleterious effects of impaired turnover of damaged mitochondria which is inherent to both familial and sporadic forms of the disease. Small-molecule inhibitors t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d660b79-2ee2-56ff-87b1-5dedef4b5c2c
DOI
10.1101/2022.09.13.507798
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule BenzosulfonamidesDOI 10.1101/2022.09.13.507798
Select a neighboring publication to make it the new centre.